Additional file 2: of Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment
Nathan Ungerleider
Sonia Rao
Ashkan Shahbandi
Douglas Yee
Tianhua Niu
Wesley Frey
James Jackson
10.6084/m9.figshare.7155671.v1
https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_of_Breast_cancer_survival_predicted_by_TP53_mutation_status_differs_markedly_depending_on_treatment/7155671
Figure S1 Overall survival curves by PAM50 classification (for A-F) all patients from METABRIC cohort; (G-L) hormone therapy-treated patients. PAM50 classification was already determined in the METABRIC cohort and accessed through cBioportal. (PDF 1142 kb)
2018-10-01 05:00:00
TP53
Breast cancer
Chemotherapy
Hormone therapy
Survival
Senescence